Synthetic Biology and Biomanufacturing with Joshua Britton from Debut Biotech

Synthetic Biology and Biomanufacturing with Joshua Britton from Debut Biotech
Near Frontier
Synthetic Biology and Biomanufacturing with Joshua Britton from Debut Biotech
/
Episode 4 February 22, 2022 00:56:28

Show Notes

Today we're joined by Dr. Joshua Britton, founder and CEO of Debut Biotech, a cell-free biomanufacturing company. Josh gives us a crash course on synthetic biology and biomanufacturing, walking us through the various methods and promise of this industry that may very well shift industrial production away from fossil fuels. We also get into some of the founding story of Debut, including how Cantos' investment in Debut came to be...hint: it had to do with a cold message. 

Shownotes:

Other Episodes

October 11, 2022

Building the BioForge w/ Sean Hunt of Solugen

We're lucky to have Sean Hunt, cofounder of Solugen, with us on Near Frontier today. We talk to Sean about the evolution of clean tech into synthetic biology, what makes Solugen special, how to build a revenue generating hard tech business, and more. Deep tech founders and investors, this is one where you'll want to pull out your notepads.   Solugen website Solugen twitter Sean's twitter ...

Play

01:01:09

April 05, 2022

Scaling Robotics with Tessa Lau of Dusty Robotics

Today we're joined by Tessa Lau, founder and CEO of Dusty Robotics, a Bay Area construction robotics company. We talk to Tessa about the vision for Dusty, how she got started, dealing with supply chain, selling into construction, and her advice for new deep tech founders. If you're interested in robotics, construction, or building hardware startups, then this episode is for you.    Dusty Robotics twitter Dusty Robotics website Tessa Lau twitter Dusty Robotics tik tok videos  ...

Play

00:49:08

August 24, 2022

The Fourth Pillar of Cancer w/ Anand Parikh of Faeth Therapeutics

Today we're joined by Anand Parikh, founder and CEO of Faeth Therapeutics. Faeth combines precision nutrition, therapeutics, and digital health to deliver a cancer-fighting program designed to deprive tumors of the nutrients they need to grow while providing optimal nutritional support to healthy tissues.  In this episode, we get into what led Anand to start Faeth, dig into the operational complexity behind the business's software, therapeutics, and nutrition aspects, discuss fundraising for an unconventional business model, and more.  Get in touch— Anand's socials Enroll in Faeth's clinical trials here Check out Faeth's open roles here   ...

Play

00:59:58